Johnson & Johnson (JNJ) Social Stream
JOHNSON & JOHNSON (JNJ) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering JNJ.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 10 | $215 | $175 | $191.111 | $178 | 7.37% |
| 2021-12-15 | 10 | $215 | $175 | $190.555 | $178 | 7.05% |
| 2022-01-26 | 9 | $215 | $175 | $189.222 | $178 | 6.3% |
| 2022-01-27 | 9 | $215 | $175 | $190 | $178 | 6.74% |
| 2022-03-07 | 10 | $215 | $175 | $189.444 | $178 | 6.43% |
| 2022-04-04 | 11 | $215 | $175 | $188.8 | $178 | 6.07% |
| 2022-04-14 | 11 | $215 | $173 | $188.6 | $178 | 5.96% |
| 2022-04-20 | 11 | $215 | $173 | $189.6 | $178 | 6.52% |
| 2022-04-21 | 11 | $215 | $173 | $191.2 | $178 | 7.42% |
| 2022-05-20 | 12 | $215 | $173 | $190.272 | $178 | 6.89% |
| 2022-06-06 | 12 | $215 | $173 | $189.818 | $178 | 6.64% |
| 2022-09-07 | 16 | $215 | $165 | $186.333 | $178 | 4.68% |
| 2022-09-17 | 16 | $215 | $165 | $186.266 | $178 | 4.64% |
| 2022-10-05 | 15 | $215 | $165 | $186.066 | $178 | 4.53% |
| 2022-10-12 | 16 | $215 | $165 | $186.066 | $178 | 4.53% |
| 2022-10-13 | 16 | $215 | $165 | $186.133 | $178 | 4.57% |
| 2022-10-14 | 16 | $215 | $165 | $185.666 | $178 | 4.31% |
| 2022-10-19 | 17 | $215 | $165 | $185.4 | $178 | 4.16% |
| 2022-10-20 | 17 | $215 | $160.001 | $184 | $178 | 3.37% |
| 2022-11-28 | 17 | $215 | $160 | $184.437 | $178 | 3.62% |
The Trend in the Analyst Price Target
Over the past 27 weeks, JNJ's average price target has gone down $5.38.
JNJ reports an average of 9% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-15 | 9 | 215 | 175 | 190.555 | 171.14 | 11.34% |
| 2022-01-27 | 9 | 215 | 175 | 190.000 | 170.59 | 11.38% |
| 2022-04-20 | 11 | 215 | 173 | 189.600 | 183.89 | 3.11% |
| 2022-04-21 | 11 | 215 | 173 | 191.200 | 183.36 | 4.28% |
| 2022-11-28 | 16 | 215 | 160 | 184.437 | 177.33 | 4.01% |
JNJ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.12 | 7 | 1 | 9 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
Over the past 31 months, JNJ's average broker recommendation rating worsened by 0.27.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- JNJ has a higher average analyst price target than 2292.59% of all US stocks.
- In the context of Pharmaceutical Products stocks, JOHNSON & JOHNSON's upside potential (average analyst target price relative to current price) is higher than 276.94% of them.
- JOHNSON & JOHNSON's variance in analysts' estimates is lower than -244.9% of stocks in the mega market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, JOHNSON & JOHNSON's number of analysts covering the stock is higher than 2232.57% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to JOHNSON & JOHNSON are PFE, LLY, and ABT.
View All Top Stocks by Price Target
Is JNJ a Buy, Hold or Sell? See the POWR Ratings now!